儿童急性疼痛评分变化与临床有意义结局的关联
该横断面研究纳入431名6–17岁(VNRS)和4–17岁(FPS-R)急性疼痛患儿,采用ROC曲线法确定与「稍微减轻」和「明显减轻」疼痛及患者因疼痛足够而拒绝额外镇痛药相对应的疼痛评分变化。VNRS的MCSD、ICSD、PPAA分别为2/10分(20%)、3/10分(44%)、2/10分(29%);FPS-R分别为2/10分(33%)、4/10分(60%)、4/10分(40%)。疼痛评分绝对变化随初始疼痛强度增加而增大,但百分比降低保持稳定;年龄、性别、种族/民族间无显著差异。
要点
- 6–17岁儿童用VNRS评估时,与「稍微减轻」疼痛对应的评分变化为2/10分(20%),与「明显减轻」对应为3/10分(44%)。
- 6–17岁儿童用VNRS评估时,与患者因疼痛足够而拒绝额外镇痛药对应的评分变化为2/10分(29%)。
- 4–17岁儿童用FPS-R评估时,与「稍微减轻」疼痛对应的评分变化为2/10分(33%),与「明显减轻」对应为4/10分(60%)。
- 4–17岁儿童用FPS-R评估时,与患者因疼痛足够而拒绝额外镇痛药对应的评分变化为4/10分(40%)。
- 疼痛评分绝对变化随初始疼痛强度增加而增大,但百分比降低保持稳定;年龄、性别、种族/民族间无显著差异。
适用人群与场景
- 6至17岁儿童使用语言数字评定量表(VNRS)评估急性疼痛。
- 4至17岁儿童使用面部疼痛量表修订版(FPS-R)评估急性疼痛。
诊断标准与关键阈值
- 最小临床显著差异(MCSD)对应「稍微减轻」疼痛:VNRS为2/10分(20%),FPS-R为2/10分(33%)。
- 理想临床显著差异(ICSD)对应「明显减轻」疼痛:VNRS为3/10分(44%),FPS-R为4/10分(60%)。
- 患者感知充分镇痛(PPAA)对应因疼痛足够而拒绝额外镇痛药:VNRS为2/10分(29%),FPS-R为4/10分(40%)。
研究设计与关键结果
- 横断面研究纳入431名患有疼痛性疾病的儿童,使用VNRS(6–17岁)和FPS-R(4–17岁)评估疼痛。
- VNRS的MCSD、ICSD、PPAA对应的疼痛评分绝对变化和百分比降低分别为2/10分和20%、3/10分和44%、2/10分和29%。
- FPS-R的MCSD、ICSD、PPAA对应的疼痛评分绝对变化和百分比降低分别为2/10分和33%、4/10分和60%、4/10分和40%。
- 疼痛评分绝对变化随初始疼痛强度增加而增大,但百分比降低保持稳定。
- 基于年龄、性别和种族/民族等患者特征无显著差异。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,本研究提供了以患者为中心的儿童结局指标,适用于设计临床试验,并可推广至不同患者特征。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Identifying changes in pain score associated with clinically meaningful outcomes is necessary when using self-report measures to assess pain in children. We aimed to determine the changes in pain score associated with a minimum clinically significant difference (MCSD), ideal clinically significant difference (ICSD), and patient-perceived adequate analgesia (PPAA) and to evaluate for differences based on initial pain intensity and patient characteristics.
METHODS: This was a cross-sectional study of children 6 to 17 and 4 to 17 years old who were assessed using the Verbal Numerical Rating Scale (VNRS) and Faces Pain Scale-Revised (FPS-R), respectively. Children qualitatively described any endorsed change in pain score; those who received an analgesic were asked if they wanted additional analgesics to decrease their pain intensity. We used a receiver operating characteristic curve-based methodology to identify changes in pain score associated with "a little less" and "much less" pain (MCSD and ICSD, respectively) and patients declining additional analgesics because of adequate analgesia (PPAA).
RESULTS: We enrolled 431 children with painful conditions. For the VNRS, raw change and percent reductions in pain scores associated with MCSD, ICSD, and PPAA were 2/10 and 20%, 3/10 and 44%, and 2/10 and 29%, respectively, and for the FPS-R, 2/10 and 33%, 4/10 and 60%, and 4/10 and 40%, respectively. Raw change in pain scores increased with increasing initial pain intensity, but percent reductions remained stable. There were no significant differences based on patient characteristics such as age, sex, and race/ethnicity.
CONCLUSION: Our findings provide patient-centered outcomes in children that are suitable for designing trials and are generalizable across patient characteristics.
参考来源
- Tsze DS, Hirschfeld G, von Baeyer CL, et al. Changes in Pain Score Associated With Clinically Meaningful Outcomes in Children With Acute Pain. Acad Emerg Med. 2019. PMID: 30636350. doi:10.1111/acem.13683
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。